SCAGLIOTTI, Giorgio Vittorio
Dettaglio
SCAGLIOTTI, Giorgio Vittorio
ONCOLOGIA
Pubblicazioni
Risultati 1 - 15 di 15 (tempo di esecuzione: 0.001 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | ALTERED MRNAS EXPRESSION OF GENES INVOLVED IN CELLULAR IRON HOMEOSTASIS IN LUNG NON SMALL CELLS CARCINOMA | 2012 | Lo Iacono M; Roetto A; Monica V; Boero M; Vavala T; Saviozzi S; Bracco E; Novello S; Papotti M; Scagliotti GV |
2 | Angiogenesis in stage in Non-Small-Cell Lung cancer (NSCLC) expression of Human protesa - activated receptors (PARS) | 2004 | GHIO P; SELVAGGI G; NOVELLO S; CAPPIA S; PAPOTTI M; GIORIO S; CAGGESE D; BORASIO P; LAUSI P; SCAGLIOTTI GV |
3 | Current state-of-the-art therapy for advanced squamous cell lung cancer | 2013 | Scagliotti, Giorgio V.; Novello, Silvia; Rapetti, Simonetta; Papotti, Mauro |
4 | Expression pattern of p53 family N-terminal isoforms in Non-Small Cell Lung Cancer | 2009 | Lo Iacono M; Ceppi P; Saviozzi S; Monica V; Pandiscia S; Billè A; Bracco E; Papotti M; Scagliotti G. |
5 | Low-dose spiral CT for early diagnosis of lung cancer in a light risk population: 2-year results | 2004 | SCAGLIOTTI GV; BORASIO P; DOGLIOTTI L; FAVA C; CORTESE G; CRIDA B; SELVAGGI G; SAINI; CARDINALE L; PLACIDO R; GRIVETTO S; NOVELLO S. |
6 | MDM2 309 and TP53 Arg72Pro single nucleotide polymorphisms (SNPs) and clinical outcome in advanced lung cancer patients | 2007 | S. Novello; G. Mandrile; D. F. Giachino; P. Ghio; G. Selvaggi; D. Gregori; M. De Marchi; G. V. Scagliotti |
7 | Non small cell lung cancer (NSCLC): accuracy of FGD PET/CT un the preoperative mediastinal nodal staging | 2007 | E. Pelosi; A. Billè; A. Skanjeti; V. Arena; A. Douroukas; S. Novello; G.V. Scagliotti; F. Ardissone; P. Borasio. |
8 | Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center | 2021 | Bungaro, M; Bertaglia, V; Audisio, M; Parlagreco, E; Pisano, C; Cetoretta, V; Persano, I; Jacobs, F; Baratelli, C; Consito, L; Reale, ML; Tabbo, F; Bironzo, P; Scagliotti, G; Novello, S |
9 | Pharmacogenetics studies in patients with advanced lung cancer: Prognostic value of the thymidylate synthase 2R/3R polymorphism and predictivity of NER factor XPD K751Q and XRCC1 R399Q polymorphisms following platinum-based chemotherapy | 2005 | Giachino, Daniela Francesca; Ghio, P.; Regazzoni, S.; Mandrile, Giorgia; Novello, Silvia; Selvaggi, G.; DE MARCHI, Mario; Scagliotti, Giorgio Vittorio |
10 | Pharmacogenetics studies in patients with advanced lungcancer: prognostic value of the thymidylate synthase 2R/3Rpolymorphism and predictivity of NER factor XPD K751Qand XRCC1 R399Q polymorphisms following platinum-basedchemotherapy | 2005 | Giachino DF; Ghio P; Regazzoni S; Mandrile G; Novello S; SelvaggiG; De Marchi; Scagliotti GV |
11 | Predictive value of thymidylate synthase in epithelial and biphasic malignant pleural mesothelioma treated with pemetrexed | 2009 | Selvaggi G; Righi L; Billè A; Ceppi P; Bacillo E; Pandiscia S; Ardissone F; Papotti MG; Scagliotti GV |
12 | Prognostic significance of osteopontin expression in malignant pleural mesothelioma | 2007 | Cappia S; Righi L; Ceppi P; Volante M; Bacillo E; Ardissone F; Mirabelli D; Scagliotti GV; Papotti M. |
13 | Prospective study assessing MDM2 309 and p53 Arg72Pro single nucleotide polymorphism (SNPs) and clinical outcome in advanced lung cancer | 2007 | Mandrile, Giorgia; Giachino, Daniela Francesca; Novello, Silvia; Paolo, Ghio; Giovanni, Selvaggi; Gregori, Dario; DE MARCHI, Mario; Scagliotti, Giorgio Vittorio |
14 | Relationship of thymidylate synthase levels to outcome of malignant pleural mesothelioma patients treated with pemetrexed-based chemotherapy | 2009 | Selvaggi G; Righi L; Ceppi P; Bacillo E; Billè A; Pandiscia S; Ardissone F; Scagliotti GV; Papotti M |
15 | Thymidylate synthase expression in large cell carcinoma ofthe lung | 2009 | Scagliotti Giorgio V.; Monica Valentina; Ceppi Paolo; Righi Luisella; Cambieri Alberto; Lo Iacono Marco; Volante Marco; Novello Silvia; Papotti Mauro |